lansoprazole has been researched along with Disease Exacerbation in 5 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chronic obstructive pulmonary disease (COPD) is a common and progressive disease characterised by chronic cough, airflow limitation and recurrent exacerbations." | 2.66 | Proton pump inhibitors for chronic obstructive pulmonary disease. ( Imai, H; Kikuchi, S; Tajiri, T; Tani, Y; Watanabe, N, 2020) |
| "Children aged 6-12 years with type 1 diabetes were allocated to receive cholecalciferol and lansoprazole (Group 1) or no treatment (Group 2)." | 1.72 | Combination therapy with lansoprazole and cholecalciferol is associated with a slower decline in residual beta-cell function and lower insulin requirements in children with recent onset type 1 diabetes: results of a pilot study. ( Attri, SV; Dayal, D; Gupta, VK; Reddy, R; Sachdeva, N, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reddy, R | 3 |
| Dayal, D | 3 |
| Sachdeva, N | 3 |
| Attri, SV | 3 |
| Gupta, VK | 3 |
| Kikuchi, S | 1 |
| Imai, H | 1 |
| Tani, Y | 1 |
| Tajiri, T | 1 |
| Watanabe, N | 1 |
| Nishi, T | 1 |
| Yamamoto, Y | 1 |
| Yamagishi, N | 1 |
| Iguchi, M | 1 |
| Tamai, H | 1 |
| Ito, T | 1 |
| Tsuruo, Y | 1 |
| Ichinose, M | 1 |
| Kitano, M | 1 |
| Ueyama, T | 1 |
| Okamoto, T | 1 |
| Hatakeyama, S | 1 |
| Hosogoe, S | 1 |
| Tanaka, Y | 1 |
| Imanishi, K | 1 |
| Takashima, T | 1 |
| Saitoh, F | 1 |
| Suzuki, T | 1 |
| Ohyama, C | 1 |
| Miyashita, T | 1 |
| Shah, FA | 1 |
| Harmon, JW | 1 |
| Marti, GP | 1 |
| Matsui, D | 1 |
| Okamoto, K | 1 |
| Makino, I | 1 |
| Hayashi, H | 1 |
| Oyama, K | 1 |
| Nakagawara, H | 1 |
| Tajima, H | 1 |
| Fujita, H | 1 |
| Takamura, H | 1 |
| Murakami, M | 1 |
| Ninomiya, I | 1 |
| Kitagawa, H | 1 |
| Fushida, S | 1 |
| Fujimura, T | 1 |
| Ohta, T | 1 |
2 reviews available for lansoprazole and Disease Exacerbation
| Article | Year |
|---|---|
Proton pump inhibitors for chronic obstructive pulmonary disease.
Topics: Aged; Disease Progression; Humans; Lansoprazole; Proton Pump Inhibitors; Pulmonary Disease, Chronic | 2020 |
Do proton pump inhibitors protect against cancer progression in GERD?
Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Barrett Esop | 2013 |
3 other studies available for lansoprazole and Disease Exacerbation